BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $169,702 | +105963.8% | 84,851 | +32.4% | 0.00% | – |
| Q1 2023 | $160 | +240.4% | 64,079 | +123.3% | 0.00% | – |
| Q4 2022 | $47 | -100.0% | 28,700 | -50.8% | 0.00% | – |
| Q3 2022 | $243,000 | +556.8% | 58,300 | +430.0% | 0.00% | – |
| Q1 2022 | $37,000 | -74.3% | 11,000 | -71.6% | 0.00% | – |
| Q1 2021 | $144,000 | -62.5% | 38,700 | -53.3% | 0.00% | – |
| Q4 2020 | $384,000 | +114.5% | 82,860 | +98.5% | 0.00% | – |
| Q4 2019 | $179,000 | -33.9% | 41,744 | -40.3% | 0.00% | – |
| Q3 2019 | $271,000 | -34.1% | 69,939 | -32.7% | 0.00% | -100.0% |
| Q2 2019 | $411,000 | +115.2% | 103,878 | +136.2% | 0.00% | – |
| Q1 2019 | $191,000 | +334.1% | 43,974 | +307.2% | 0.00% | – |
| Q3 2017 | $44,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
| EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
| Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
| CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
| HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
| Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |